ESC Premium Access

Oral anticoagulation therapy with rivaroxaban in elderly patients with atrial fibrillation. Results from EMIR study.

Congress Presentation

About the speaker

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Thumbnail

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Thumbnail

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Thumbnail

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Thumbnail

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Doctor M. Esteve Pastor, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: how to implement the guidelines and take-home message.

27 August 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: what do the guidelines say?

27 August 2021

ESC Premium Access

The COVID-19 pandemic: a multiple (cardiovascular) hit?

27 August 2021

ESC 365 is supported by

logo Novo Nordisk